CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants
- 29 March 2015
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 169 (6) , 868-878
Abstract
Summary: The success of haematopoietic stem cell (HSC) transplantation largely depends on numbers of transplanted HSCs, which reside in the CD34+ populations of bone marrow (BM), peripheral blood stem cells (PBSC) and umbilical cord blood (UCB). More specifically HSCs reside in the CD38low/− subpopulation, which cannot be objectively discriminated from mature CD34+ CD38+ progenitors. Thus, better marker combinations for the quantification of more primitive haematopoietic stem and progenitor cells in transplants are required. Recently, by combining CD34 and CD133 we could clearly distinguish CD133+ CD34+ multipotent and lympho‐myeloid from CD133low CD34+ erythro‐myeloid progenitors in UCB samples. To qualify the assessment of CD133 for routine quality control of adult HSC sources, we analysed the developmental potentials of CD133+ and CD133low subpopulations in BM and PBSC. Similar to UCB, CD133 expression objectively discriminated functionally distinct subpopulations in adult HSC sources. By implementing anti‐CD45RA staining, which separates multipotent (CD133+ CD34+ CD45RA−) from lympho‐myeloid (CD133+ CD34+ CD45RA+) progenitor fractions, UCB was found to contain 2–3 times higher multipotent progenitor frequencies than BM and PBSC. To test for the consistency of CD133 expression, we compared CD133+ CD34+ contents of 128 UCB samples with maternal and obstetrical factors and obtained similar correlations to related studies focusing on CD34+ cell contents. In conclusion, implementation of anti‐CD133 staining into existing routine panels will improve the quality control analyses for HSC transplants.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (GI 336/4-1)
This publication has 41 references indexed in Scilit:
- Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell CocultureNew England Journal of Medicine, 2012
- Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitutionNature Medicine, 2010
- Cesarean section due to fetal distress increases the number of stem cells in umbilical cord bloodTransfusion, 2008
- Double umbilical cord blood transplantationCurrent Opinion in Immunology, 2006
- Primitive human hematopoietic cells give rise to differentially specified daughter cells upon their initial cell divisionBlood, 2006
- Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cellsBlood, 2004
- Distinct hematopoietic stem/progenitor cell populations are responsible for repopulating NOD/SCID mice compared with nonhuman primatesBlood, 2003
- CD34+AC133+Cells Isolated from Cord Blood are Highly Enriched in Long‐Term Culture‐Initiating Cells, NOD/SCID‐Repopulating Cells and Dendritic Cell ProgenitorsStem Cells, 1998
- Phenotypic Analysis and Characterization of CD34+ Cells from Normal Human Bone Marrow, Cord Blood, Peripheral Blood, and Mobilized Peripheral Blood from Patients Undergoing Autologous Stem Cell TransplantationClinical Immunology and Immunopathology, 1994
- Hematopoietic Reconstitution in a Patient with Fanconi's Anemia by Means of Umbilical-Cord Blood from an HLA-Identical SiblingNew England Journal of Medicine, 1989